With historical data showing migraine to be underdiagnosed and undertreated, new guidance from the American College of ...

Sarah Anderson, oncology strategy lead director, Novotech, discusses the significance of triple-negative breast cancer ...

Amid the uproar over the firing of 18 inspectors general, a report offering a coda to the aducanumab approval episode has ...

A polypill for preventing cardiovascular disease has the potential to address health inequities and expand health care access ...

While all poly ADP-ribose polymerase (PARP) inhibitors improved progression-free survival, olaparib significantly extended overall survival (OS), making it a preferred option.

The American Gastroenterology Association (AGA) updated its clinical practice guidelines for managing hepatitis B ...

A looming Supreme Court ruling will answer questions about the legality of the Affordable Care Act mandate for providing some ...

Adam Colborn, JD, of AMCP, discussed how President Trump's rescission of several Biden-era executive orders may impact ...

Robert F. Kennedy Jr sat before the Senate for 2 separate hearings, to decide the fate of his confirmation as secretary of ...

Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...

The asymptomatic nature of glaucoma makes it imperative to get consistent screening to catch the condition early.

Gladys Antelo-Allen of Camden Coalition discusses a new skills lab offering accessible learning modules with 12 microlessons ...